Key Insights

Highlights

Treatment Research

6 treatments under study, led by Furosemide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Withdrawn1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Furosemide1
  • Tavns On Earlobe Of Subjects With No High Trait Anxiety1
  • Tavns On Earlobe Of Subjects With High Trait Anxiety1
  • Tavns On Tragus Of Subjects With High Trait Anxiety1
  • Tavns On Tragus Of Subjects With No High Trait Anxiety1

Active Sponsors

  • Universitätsklinikum Hamburg-Eppendorf1
  • University of Electronic Science and Technology of China1

Top Investigators

  • Institut für Experimentelle und Klinische Pharmakologie und Toxikologie Universitätsklinikum Hamburg-Eppendorf Martinistr. 52 20246 Hamburg GERMANY

  • University of Electronic Science and Technology of China

  • Institut für Experimentelle und Klinische Pharmakologie und Toxikologie Universitätsklinikum Hamburg-Eppendorf Martinistr. 52 20246 Hamburg GERMANY

Activity Timeline